Ephrin-B2 (EB2) is known to act as main entry receptor for NiV [20,21], and its expression on endothelial cells, smooth muscle cells and neurons [22-26] is highly consistent with the known tropism of NiV infection in vivo [13]. The gene discussed is MAPRE2; the disease is infection.